文献速递关节外科

钙剂与维生素D使用与全膝关节置换术后假体生存的关联:一项全国性基于人群的队列研究

The Association of Calcium and Vitamin D Use With Implant Survival of Total Knee Arthroplasty: A Nationwide Population-Based Cohort Study.
PubMed 文献 · J Arthroplasty · 2020-08-06

该研究利用韩国国民健康保险数据库,纳入2009年至2018年间接受初次全膝关节置换术的膝骨关节炎患者,比较钙剂与维生素D使用者与从未使用者之间的翻修风险。结果显示,联合使用超过1年与翻修风险降低相关,且假体生存率显著改善。

要点

  • 钙剂与维生素D联合使用超过1年者,假体生存率显著优于从未使用者(log-rank P < .001)。
  • 联合使用超过1年与翻修风险降低相关:合并假体周围感染患者aHR 0.63(95%CI 0.42-0.95),无感染患者aHR 0.70(95%CI 0.54-0.91)。
  • 使用剂量≥800 IU且超过1年的联合使用,与翻修手术风险的最大程度降低相关。

核心结论

  • 钙剂与维生素D联合使用(剂量≥800 IU且超过1年)与全膝关节置换术后翻修手术风险的最大程度降低相关。

研究设计与样本

  • 全国性基于人群的队列研究,使用韩国国民健康保险数据库,纳入2009年至2018年间诊断为膝骨关节炎并接受初次全膝关节置换术的患者。
  • 共纳入142,147例受试者,其中钙剂与维生素D使用者28,403例,从未使用者113,744例。
  • 采用含时依协变量的Cox比例风险模型估计翻修风险,并用log-rank检验评估膝关节置换假体生存。

主要发现

  • 在6个月用药滞后期的条件下,钙剂与维生素D使用显著降低翻修风险(aHR 0.56,95%CI 0.45-0.70)。
  • 联合使用超过1年与翻修风险降低相关:合并假体周围感染患者aHR 0.63(95%CI 0.42-0.95),无感染患者aHR 0.70(95%CI 0.54-0.91)。
  • 联合使用超过1年者的假体生存率显著优于从未使用者(log-rank P < .001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Calcium and vitamin D have been regarded as beneficial nutrients for bone metabolism that may affect survival of arthroplasties. However, the relationship between their use and revision rate of knee arthroplasty has not been evaluated. Thus, we investigated an association between calcium and vitamin D use and the revision rate after primary total knee arthroplasty. METHODS: A nationwide population-based cohort study was conducted using the Korean National Health Insurance database. We included patients diagnosed with knee osteoarthritis and underwent primary total knee arthroplasty between 2009 and 2018. Risk for arthroplasty revision was estimated using a Cox proportional hazards model with time-dependent covariates. Log-rank test was used to assess survival of knee arthroplasty. RESULTS: Out of 142,147 subjects, 28,403 were calcium and vitamin D users and 113,744 were never users. Calcium and vitamin D significantly reduced the revision risk with a 6-month drug use lag period (adjusted hazard ratio [aHR] 0.56, 95% confidence interval [CI] 0.45-0.70). Calcium and vitamin D combination use for more than 1 year was associated with reduced revision risks in both patients with periprosthetic joint infection (aHR 0.63, 95% CI 0.42-0.95) and patients without infection (aHR 0.70, 95% CI 0.54-0.91). Implant survival was significantly improved in calcium and vitamin D combination users for more than 1 year compared with never users (log-rank P < .001). CONCLUSION: Combination use of calcium and vitamin D with a dose of 800 IU or greater for more than 1 year was associated with the greatest reduction in the risks for revision surgery after total knee arthroplasty.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kong Y, Han M, Lee M, et al. The Association of Calcium and Vitamin D Use With Implant Survival of Total Knee Arthroplasty: A Nationwide Population-Based Cohort Study. J Arthroplasty. 2020. PMID: 32888752. doi:10.1016/j.arth.2020.08.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。